References
- Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. (2003a). Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: A double blind, randomized and placebo-controlled trial. J Clin Pharm Ther, 28, 53–59.
- Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. (2003b). Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: A double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psychiatr, 74, 863–866.
- Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. (2011). Alzheimer’s disease. Lancet, 377, 1019–1031.
- Bradford MM. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, 248–254.
- Craveiro ACS, Carvalho DMM, Nunes RS, Fakhouri R, Rodrigues SA, Teixeira-Silva F. (2008). Toxicidade aguda do extrato aquoso de folhas de Erythrina velutina em animais experimentais. Brazilian J Pharmacog, 18, 739–743.
- Dantas MC, De Oliveira FS, Bandeira SM, Batista JS, Silva CD Jr, Alves PB, Antoniolli AR, Marchioro M. (2004). Central nervous system effects of the crude extract of Erythrina velutina on rodents. J Ethnopharmacol, 94, 129–133.
- Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 7, 88–95.
- European Treaty Series (2005). European convention for the protection of vertebrate animals used for experimental and other scientific purposes. European Treaty Series, Strasbourg, ETS-123. Available at: http://conventions.coe.int/Treaty/en/Treaties/html/123.htm. Accessed on 30 June 2011.
- Lane RM, Potkin SG, Enz A. (2006). Targeting acetylcholinesterase and butyrylcholinesterase in dementia. Int J Neuropsychopharmacol, 9, 101–124.
- Marchioro M, Blank M, de F, Mourão RH, Antoniolli AR.. (2005). Anti-nociceptive activity of the aqueous extract of Erythrina velutina leaves. Fitoterapia, 76, 637–642.
- Matos FJA. (1997). O formulário fitoterápico do professor Dias da Rocha, Universidade Federal do Ceará Edições, Fortaleza, Brazil.
- Mega MS, Cummings JL, Fiorello T, Gornbein J. (1996). The spectrum of behavioral changes in Alzheimer’s disease. Neurology, 46, 130–135.
- Mukherjeea PK, Kumarb V, Malb M, Houghtona PJ. (2007). Acetylcholinesterase inhibitors from plants. Phytomedicine, 14, 289–300.
- Teske M, Trentini AMM. (1995). Herbarium: Conpêndio de Fitoterapia, Herbarium Laboratório Botânico, Curitiba, Brazil.
- Weinmann S, Roll S, Schwarzbach C, Vauth C, Willich SN. (2010). Effects of Ginkgo biloba in dementia: Systematic review and meta-analysis. BMC Geriatr, 10, 14.
- Wang R, Yan H, Tang XC. (2006). Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol Sin, 27, 1–26.